Expertise
Myocardial Infarction
Venous Thrombosis
Drug-Eluting Stents
Stents
Therapeutics
Everolimus
Odds Ratio
Zotarolimus
Organizations
Publications
Recent
Zocca, P., Kok, M. M., van der Heijden, L. C., Danse, P. W., Schotborgh, C. E., Scholte, M., ... von Birgelen, C. (2018). High Bleeding Risk Patients Treated with Very Thin-Strut Biodegradable Polymer or Thin-Strut Durable Polymer Drug-Eluting Stents in the BIO-RESORT Trial. Cardiovascular Drugs and Therapy. DOI: 10.1007/s10557-018-6823-9
Bentum, S., Hendriks, J., Doggen, C., Egberink, R., Sandvliet, R., & Pierik, J. (2018). Hartpatiënt moet meer weten over alarmsymptomen. Huisarts en wetenschap, 61(4), 14-17. DOI: 10.1007/s12445-018-0097-0
Zocca, P., Kok, M. M., van der Heijden, L. C., van Houwelingen, K. G., Hartmann, M., de Man, F. H. A. F., ... von Birgelen, C. (2018). High bleeding risk patients with acute coronary syndromes treated with contemporary drug-eluting stents and Clopidogrel or Ticagrelor: Insights from CHANGE DAPT. International journal of cardiology, 268, 11-17. DOI: 10.1016/j.ijcard.2018.03.116
Kok, M. M., von Birgelen, C., Sattar, N., Zocca, P., Löwik, M. M., Danse, P. W., ... van der Heijden, L. C. (2018). Prediabetes and its Impact on Clinical Outcome After Coronary Intervention in a Broad Patient Population. EuroIntervention. DOI: 10.4244/EIJ-D-17-01067
Ospina-Romero, M., Cannegieter, S. C., Den Heijer, M., Doggen, C. J. M., Rosendaal, F. R., & Lijfering, W. M. (2018). Hyperhomocysteinemia and Risk of First Venous Thrombosis: The Influence of (Unmeasured) Confounding Factors. American Journal of Epidemiology, 187(7), 1392-1400. DOI: 10.1093/aje/kwy004
Kok, M. M., Zocca, P., Buiten, R. A., Danse, P. W., Schotborgh, C. E., Scholte, M., ... von Birgelen, C. (2018). Two-year clinical outcome of all-comers treated with three highly dissimilar contemporary coronary drug-eluting stents in the randomised BIO-RESORT trial. EuroIntervention. DOI: 10.4244/EIJ-D-18-00336
Kandhai-Ragunath, J. J., Doggen, C. J. M., van der Heijden, L. C., Kok, M. M., Zocca, P., de Wagenaar, B., ... von Birgelen, C. (2018). Serial assessment of endothelial function 1, 6, and 12 months after ST-elevation myocardial infarction. Heart and vessels, 33(9), 978–985. DOI: 10.1007/s00380-018-1145-1
Busger op Vollenbroek, F. T. M., Doggen, C. J. M., Janssens, R. W. A., & Bernelot Moens, H. J. (2018). Dermatological guidelines for monitoring methotrexate treatment reduce drug-survival compared to rheumatological guidelines. PLoS ONE, 13(3), [e0194401]. DOI: 10.1371/journal.pone.0194401
von Birgelen, C., Kok, M. M., Sattar, N., Zocca, P., Doelman, C., Kant, G. D., ... Tandjung, K. (2018). “Silent” Diabetes and Clinical Outcome After Treatment With Contemporary Drug-Eluting Stents: The BIO-RESORT Silent Diabetes Study. JACC : cardiovascular interventions, 11(5), 448-459. DOI: 10.1016/j.jcin.2017.10.038
Zocca, P., Kok, M. M., Tandjung, K., Danse, P. W., Jessurun, G. A. J., Hautvast, R. W. M., ... von Birgelen, C. (2018). 5-Year Outcome Following Randomized Treatment of All-Comers With Zotarolimus-Eluting Resolute Integrity and Everolimus-Eluting PROMUS Element Coronary Stents: Final Report of the DUTCH PEERS (TWENTE II) Trial. JACC : cardiovascular interventions, 11(5), 500-502. DOI: 10.1016/j.jcin.2017.11.031
UT Research Information System
Courses
Contact Details
Visiting Address
University of Twente
Faculty of Behavioural, Management and Social Sciences
Ravelijn
(building no. 10), room 5248
Hallenweg 17
7522NH Enschede
The Netherlands
Mailing Address
University of Twente
Faculty of Behavioural, Management and Social Sciences
Ravelijn
5248
P.O. Box 217
7500 AE Enschede
The Netherlands